» HealthSphere Insights
Results results found
No items match your search/filter criteria
The Pox-Protein Public-Private Partnership (P5)—has enlisted Shift Health to help advance priorities and achieve several partnership goals over the course of a multi-year product development plan
Public-private partnerships (P3s) have become an increasingly pivotal—almost doctrinal—driver of R&D across the health sciences. But for all the advantages that have made P3s increasingly inevitable, these partnerships have not become less complex.
Shift Health co-hosted a Product Development Boot Camp with the Global HIV Vaccine Enterprise. Ryan Wiley, PhD, President at Shift Health, delivered an overview of product development partnerships.
Shift Health co-hosted a Product Development Boot Camp with the Global HIV Vaccine Enterprise. The Boot Camp afforded workshop participants […]
Clinical innovation takes root in a centre that embraces a culture of evidence-based medicine, where patients’ needs drive research and […]
Responsible for assessing and managing intellectual property (IP) and acting as an industry/investor liaison, Technology Transfer Offices (TTOs) play a […]
At the most rudimentary level, a Functional Innovation System (FIS) must balance the push forces of knowledge creation with the […]
The Middle East and North Africa (MENA) region is a diverse, complex, dynamic tapestry of contrasts. MENA countries are pouring […]
At Healthcare World Asia 2012 in Singapore, Shift Health President Dr. Ryan Wiley led a discussion about key questions shaping […]
In order to download the PDF, please fill out the following form: